Log in | Register

The Intensive Care Medicine research agenda on critically ill oncology and hematology patients

Elie Azoulay| Peter Schellongowski| Michael Darmon| Philippe R. Bauer| Dominique Benoit| Pieter Depuydt| Jigeeshu V. Divatia| Virginie Lemiale| Maarten van Vliet| Anne-Pascale Meert| Djamel Mokart| Stephen M. Pastores| Anders Perner| Frédéric Pène| Peter Pickkers| Kathryn A. Puxty| Francois Vincent| Jorge Salluh| Ayman O. Soubani| Massimo Antonelli| Thomas Staudinger| Michael von Bergwelt-Baildon|
Research Agenda
Volume 43, Issue 9 / September , 2017

Pages 1366 - 1382

Abstract

Over the coming years, accelerating progress against cancer will be associated with an increased number of patients who require life-sustaining therapies for infectious or toxic chemotherapy-related events. Major changes include increased number of cancer patients admitted to the ICU with full-code status or for time-limited trials, increased survival and quality of life in ICU survivors, changing prognostic factors, early ICU admission for optimal monitoring, and use of noninvasive diagnostic and therapeutic strategies. In this review, experts in the management of critically ill cancer patients highlight recent changes in the use and the results of intensive care in patients with malignancies. They seek to put forward a standard of care for the management of these patients and highlight important updates that are required to care for them. The research agenda they suggest includes important studies to be conducted in the next few years to increase our understanding of organ dysfunction in this population and to improve our ability to appropriately use life-saving therapies or select new therapeutic approaches that are likely to improve outcomes. This review aims to provide more guidance for the daily management of patients with cancer, in whom outcomes are constantly improving, as is our global ability to fight against what is becoming the leading cause of mortality in industrialized and non-industrialized countries.

Keywords

References

  1. Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH, Stein KD, Alteri R, Jemal A (2016) Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin 66:271–289
    • View reference on PubMed
    • View reference on publisher's website
  2. Siegel RL, Miller KD, Jemal A (2016) Cancer statistics, 2016. CA Cancer J Clin 66:7–30
    • View reference on PubMed
    • View reference on publisher's website
  3. Shimabukuro-Vornhagen A, Boll B, Kochanek M, Azoulay E, von Bergwelt-Baildon MS (2016) Critical care of patients with cancer. CA Cancer J Clin 2016:21351
  4. Lee DW, Gardner R, Porter DL, Louis CU, Ahmed N, Jensen M, Grupp SA, Mackall CL (2014) Current concepts in the diagnosis and management of cytokine release syndrome. Blood 124:188–195
    • View reference on PubMed
    • View reference on publisher's website
  5. Peigne V, Rusinova K, Karlin L, Darmon M, Fermand JP, Schlemmer B, Azoulay E (2009) Continued survival gains in recent years among critically ill myeloma patients. Intensive Care Med 35:512–518
  6. Soares M, Bozza FA, Azevedo LC, Silva UV, Correa TD, Colombari F, Torelly AP, Varaschin P, Viana WN, Knibel MF, Damasceno M, Espinoza R, Ferez M, Silveira JG, Lobo SA, Moraes AP, Lima RA, de Carvalho AG, do Brasil PE, Kahn JM, Angus DC, Salluh JI (2016) Effects of organizational characteristics on outcomes and resource use in patients with cancer admitted to intensive care units. J Clin Oncol 34:3315–3324
    • View reference on PubMed
    • View reference on publisher's website
  7. Schellongowski P, Staudinger T, Kundi M, Laczika K, Locker GJ, Bojic A, Robak O, Fuhrmann V, Jager U, Valent P, Sperr WR (2011) Prognostic factors for intensive care unit admission, intensive care outcome, and post-intensive care survival in patients with de novo acute myeloid leukemia: a single center experience. Haematologica 96:231–237
    • View reference on PubMed
    • View reference on publisher's website
  8. Azoulay E, Mokart D, Pene F, Lambert J, Kouatchet A, Mayaux J, Vincent F, Nyunga M, Bruneel F, Laisne LM, Rabbat A, Lebert C, Perez P, Chaize M, Renault A, Meert AP, Benoit D, Hamidfar R, Jourdain M, Darmon M, Schlemmer B, Chevret S, Lemiale V (2013) Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from France and Belgium—a groupe de recherche respiratoire en reanimation onco-hematologique study. J Clin Oncol 31:2810–2818
    • View reference on PubMed
    • View reference on publisher's website
  9. Azoulay E, Pene F, Darmon M, Lengline E, Benoit D, Soares M, Vincent F, Bruneel F, Perez P, Lemiale V, Mokart D (2015) Managing critically ill hematology patients: time to think differently. Blood Rev 29:359–367
    • View reference on PubMed
    • View reference on publisher's website
  10. Azoulay E, Mokart D, Lambert J, Lemiale V, Rabbat A, Kouatchet A, Vincent F, Gruson D, Bruneel F, Epinette-Branche G, Lafabrie A, Hamidfar-Roy R, Cracco C, Renard B, Tonnelier JM, Blot F, Chevret S, Schlemmer B (2010) Diagnostic strategy for hematology and oncology patients with acute respiratory failure: randomized controlled trial. Am J Respir Crit Care Med 182:1038–1046
    • View reference on PubMed
    • View reference on publisher's website
  11. Azoulay E, Soares M, Darmon M, Benoit D, Pastores S, Afessa B (2011) Intensive care of the cancer patient: recent achievements and remaining challenges. Ann Intensive Care 1:5
    • View reference on PubMed
    • View reference on publisher's website
  12. de Lange DW, Wunsch H, Kesecioglu J (2015) Comparing intensive care units by size or level. Intensive Care Med 41:357–359
  13. Soares M, Silva UV, Homena WS Jr, Fernandes GC, De Moraes AP, Brauer L, Lima MF, De Marco FV, Bozza FA, Salluh JI (2016) Family care, visiting policies, ICU performance, and efficiency in resource use: insights from the ORCHESTRA study. Intensive Care Med 2016:016–4654
  14. Escher M, Perneger TV, Chevrolet JC (2004) National questionnaire survey on what influences doctors’ decisions about admission to intensive care. BMJ 329:425
    • View reference on PubMed
    • View reference on publisher's website
  15. Robert R, Reignier J, Tournoux-Facon C, Boulain T, Lesieur O, Gissot V, Souday V, Hamrouni M, Chapon C, Gouello JP (2012) Refusal of intensive care unit admission due to a full unit: impact on mortality. Am J Respir Crit Care Med 185:1081–1087
    • View reference on PubMed
    • View reference on publisher's website
  16. Squadrone V, Massaia M, Bruno B, Marmont F, Falda M, Bagna C, Bertone S, Filippini C, Slutsky AS, Vitolo U, Boccadoro M, Ranieri VM (2010) Early CPAP prevents evolution of acute lung injury in patients with hematologic malignancy. Intensive Care Med 36:1666–1674
  17. Mokart D, Lambert J, Schnell D, Fouche L, Rabbat A, Kouatchet A, Lemiale V, Vincent F, Lengline E, Bruneel F, Pene F, Chevret S, Azoulay E (2012) Delayed intensive care unit admission is associated with increased mortality in patients with cancer with acute respiratory failure. Leuk Lymphoma 54:1724–1729
    • View reference on PubMed
    • View reference on publisher's website
  18. Lengline E, Raffoux E, Lemiale V, Darmon M, Canet E, Boissel N, Schlemmer B, Dombret H, Azoulay E (2012) Intensive care unit management of patients with newly diagnosed acute myeloid leukemia with no organ failure. Leuk Lymphoma 53:1352–1359
    • View reference on PubMed
    • View reference on publisher's website
  19. Skrifvars M, Martin-Loeches I (2016) Finally time for rapid response systems to be well MET in Europe? Intensive Care Med 42:608–610
  20. Young RS, Gobel BH, Schumacher M, Lee J, Weaver C, Weitzman S (2014) Use of the modified early warning score and serum lactate to prevent cardiopulmonary arrest in hematology-oncology patients: a quality improvement study. Am J Med Qual 29:530–537
    • View reference on PubMed
    • View reference on publisher's website
  21. Azoulay E, Thiery G, Chevret S, Moreau D, Darmon M, Bergeron A, Yang K, Meignin V, Ciroldi M, Le Gall JR, Tazi A, Schlemmer B (2004) The prognosis of acute respiratory failure in critically ill cancer patients. Medicine (Baltimore) 83:360–370
    • View reference on publisher's website
  22. Baillard C, Fosse JP, Sebbane M, Chanques G, Vincent F, Courouble P, Cohen Y, Eledjam JJ, Adnet F, Jaber S (2006) Noninvasive ventilation improves preoxygenation before intubation of hypoxic patients. Am J Respir Crit Care Med 174:171–177
    • View reference on PubMed
    • View reference on publisher's website
  23. Schnell D, Mayaux J, Lambert J, Roux A, Moreau AS, Zafrani L, Canet E, Lemiale V, Darmon M, Azoulay E (2013) Clinical assessment for identifying causes of acute respiratory failure in cancer patients. Eur Respir J 42:435–443
    • View reference on PubMed
    • View reference on publisher's website
  24. Wijers SC, Boelens JJ, Raphael MF, Beek FJ, de Jong PA (2011) Does high-resolution CT has diagnostic value in patients presenting with respiratory symptoms after hematopoietic stem cell transplantation? Eur J Radiol 80:e536–e543
    • View reference on PubMed
    • View reference on publisher's website
  25. Chellapandian D, Lehrnbecher T, Phillips B, Fisher BT, Zaoutis TE, Steinbach WJ, Beyene J, Sung L (2015) Bronchoalveolar lavage and lung biopsy in patients with cancer and hematopoietic stem-cell transplantation recipients: a systematic review and meta-analysis. J Clin Oncol 33:501–509
    • View reference on PubMed
    • View reference on publisher's website
  26. Contejean A, Lemiale V, Resche-Rigon M, Mokart D, Pene F, Kouatchet A, Mayaux J, Vincent F, Nyunga M, Bruneel F, Rabbat A, Perez P, Meert AP, Benoit D, Hamidfar R, Darmon M, Jourdain M, Renault A, Schlemmer B, Azoulay E (2017) Increased mortality in hematological malignancy patients with acute respiratory failure from undetermined etiology: a Groupe de Recherche en Reanimation Respiratoire en Onco-Hematologique (Grrr-OH) study. Ann Intensive Care 6:102
    • View reference on publisher's website
  27. Demoule A, Chevret S, Carlucci A, Kouatchet A, Jaber S, Meziani F, Schmidt M, Schnell D, Clergue C, Aboab J, Rabbat A, Eon B, Guerin C, Georges H, Zuber B, Dellamonica J, Das V, Cousson J, Perez D, Brochard L, Azoulay E (2016) Changing use of noninvasive ventilation in critically ill patients: trends over 15 years in francophone countries. Intensive Care Med 42:82–92
  28. Lemiale V, Mokart D, Resche-Rigon M, Pene F, Mayaux J, Faucher E, Nyunga M, Girault C, Perez P, Guitton C, Ekpe K, Kouatchet A, Theodose I, Benoit D, Canet E, Barbier F, Rabbat A, Bruneel F, Vincent F, Klouche K, Loay K, Mariotte E, Bouadma L, Moreau AS, Seguin A, Meert AP, Reignier J, Papazian L, Mehzari I, Cohen Y, Schenck M, Hamidfar R, Darmon M, Demoule A, Chevret S, Azoulay E (2016) Effect of noninvasive ventilation vs oxygen therapy on mortality among immunocompromised patients with acute respiratory failure: a randomized clinical trial. JAMA 314:1711–1719
    • View reference on publisher's website
  29. Benoit DD, Soares M, Azoulay E (2014) Has survival increased in cancer patients admitted to the ICU? We are not sure. Intensive Care Med 40:1576–1579
  30. Mokart D, Pastores SM, Darmon M (2014) Has survival increased in cancer patients admitted to the ICU? Yes. Intensive Care Med 40:1570–1572
  31. Pene F, Salluh JI, Staudinger T (2014) Has survival increased in cancer patients admitted to the ICU? No. Intensive Care Med 40:1573–1575
  32. Hilbert G, Gruson D, Vargas F, Valentino R, Gbikpi-Benissan G, Dupon M, Reiffers J, Cardinaud JP (2001) Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure. N Engl J Med 344:481–487
    • View reference on PubMed
    • View reference on publisher's website
  33. Gristina GR, Antonelli M, Conti G, Ciarlone A, Rogante S, Rossi C, Bertolini G (2011) Noninvasive versus invasive ventilation for acute respiratory failure in patients with hematologic malignancies: a 5-year multicenter observational survey. Crit Care Med 39:2232–2239
    • View reference on PubMed
    • View reference on publisher's website
  34. Neuschwander A, Lemiale V, Darmon M, Pene F, Kouatchet A, Perez P, Vincent F, Mayaux J, Benoit D, Bruneel F, Meert AP, Nyunga M, Rabbat A, Mokart D, Azoulay E (2017) Noninvasive ventilation during acute respiratory distress syndrome in patients with cancer: trends in use and outcome. J Crit Care 38:295–299
    • View reference on PubMed
    • View reference on publisher's website
  35. Frat JP, Thille AW, Mercat A, Girault C, Ragot S, Perbet S, Prat G, Boulain T, Morawiec E, Cottereau A, Devaquet J, Nseir S, Razazi K, Mira JP, Argaud L, Chakarian JC, Ricard JD, Wittebole X, Chevalier S, Herbland A, Fartoukh M, Constantin JM, Tonnelier JM, Pierrot M, Mathonnet A, Beduneau G, Deletage-Metreau C, Richard JC, Brochard L, Robert R (2015) High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med 372:2185–2196
    • View reference on PubMed
    • View reference on publisher's website
  36. Frat JP, Ragot S, Girault C, Perbet S, Prat G, Boulain T, Demoule A, Ricard JD, Coudroy R, Robert R, Mercat A, Brochard L, Thille AW (2016) Effect of non-invasive oxygenation strategies in immunocompromised patients with severe acute respiratory failure: a post hoc analysis of a randomised trial. Lancet Respir Med 4:646–652
    • View reference on PubMed
    • View reference on publisher's website
  37. Lemiale V, Resche-Rigon M, Mokart D, Pene F, Argaud L, Mayaux J, Guitton C, Rabbat A, Girault C, Kouatchet A, Vincent F, Bruneel F, Nyunga M, Seguin A, Klouche K, Colin G, Kontar L, Perez P, Meert AP, Benoit DD, Papazian L, Demoule A, Chevret S, Azoulay E (2016) High-flow nasal cannula oxygenation in immunocompromised patients with acute hypoxemic respiratory failure: a Groupe de Recherche Respiratoire en Reanimation Onco-Hematologique Study. Crit Care Med 45:e274–e280
    • View reference on publisher's website
  38. Neto AS, Jaber S (2016) What’s new in mechanical ventilation in patients without ARDS: lessons from the ARDS literature. Intensive Care Med 42:787–789
  39. Papazian L, Calfee CS, Chiumello D, Luyt CE, Meyer NJ, Sekiguchi H, Matthay MA, Meduri GU (2016) Diagnostic workup for ARDS patients. Intensive Care Med 42:674–685
  40. Bein T, Grasso S, Moerer O, Quintel M, Guerin C, Deja M, Brondani A, Mehta S (2016) The standard of care of patients with ARDS: ventilatory settings and rescue therapies for refractory hypoxemia. Intensive Care Med 42:699–711
  41. Brochard L (2017) Ventilation-induced lung injury exists in spontaneously breathing patients with acute respiratory failure: yes. Intensive Care Med 43:250–252
  42. Azoulay E, Lemiale V, Mokart D, Pene F, Kouatchet A, Perez P, Vincent F, Mayaux J, Benoit D, Bruneel F, Meert AP, Nyunga M, Rabbat A, Darmon M (2014) Acute respiratory distress syndrome in patients with malignancies. Intensive Care Med 40:1106–1114
  43. Ognibene FP, Martin SE, Parker MM, Schlesinger T, Roach P, Burch C, Shelhamer JH, Parrillo JE (1986) Adult respiratory distress syndrome in patients with severe neutropenia. N Engl J Med 315:547–551
    • View reference on PubMed
    • View reference on publisher's website
  44. Azoulay E, Darmon M (2010) Acute respiratory distress syndrome during neutropenia recovery. Crit Care 14:114
    • View reference on PubMed
    • View reference on publisher's website
  45. Mokart D, Darmon M, Resche-Rigon M, Lemiale V, Pene F, Mayaux J, Rabbat A, Kouatchet A, Vincent F, Nyunga M, Bruneel F, Lebert C, Perez P, Renault A, Hamidfar R, Jourdain M, Meert AP, Benoit D, Chevret S, Azoulay E (2015) Prognosis of neutropenic patients admitted to the intensive care unit. Intensive Care Med 41:296–303
  46. Wohlfarth P, Ullrich R, Staudinger T, Bojic A, Robak O, Hermann A, Lubsczyk B, Worel N, Fuhrmann V, Schoder M, Funovics M, Rabitsch W, Knoebl P, Laczika K, Locker GJ, Sperr WR, Schellongowski P (2014) Extracorporeal membrane oxygenation in adult patients with hematologic malignancies and severe acute respiratory failure. Crit Care 18:R20
    • View reference on PubMed
    • View reference on publisher's website
  47. Adda M, Coquet I, Darmon M, Thiery G, Schlemmer B, Azoulay E (2008) Predictors of noninvasive ventilation failure in patients with hematologic malignancy and acute respiratory failure. Crit Care Med 36:2766–2772
    • View reference on PubMed
    • View reference on publisher's website
  48. Mourad M, Chow-Chine L, Faucher M, Sannini A, Brun JP, de Guibert JM, Fouche L, Lambert J, Blache JL, Mokart D (2014) Early diastolic dysfunction is associated with intensive care unit mortality in cancer patients presenting with septic shock. Br J Anaesth 112:102–109
    • View reference on PubMed
    • View reference on publisher's website
  49. de Almeida JP, Palomba H, Galas FR, Fukushima JT, Duarte FA, Nagaoka D, Torres V, Yu L, Vincent JL, Auler JO Jr, Hajjar LA (2012) Positive fluid balance is associated with reduced survival in critically ill patients with cancer. Acta Anaesthesiol Scand 56:712–717
    • View reference on PubMed
    • View reference on publisher's website
  50. Karvunidis T, Chvojka J, Lysak D, Sykora R, Krouzecky A, Radej J, Novak I, Matejovic M (2012) Septic shock and chemotherapy-induced cytopenia: effects on microcirculation. Intensive Care Med 38:1336–1344
  51. Schnell D, Besset S, Lengline E, Maziers N, Zafrani L, Reuter D, Moreau AS, Canet E, Lemiale V, Azoulay E (2013) Impact of a recent chemotherapy on the duration and intensity of the norepinephrine support during septic shock. Shock 39:138–143
    • View reference on PubMed
    • View reference on publisher's website
  52. Cecconi M, Hofer C, Teboul JL, Pettila V, Wilkman E, Molnar Z, Della Rocca G, Aldecoa C, Artigas A, Jog S, Sander M, Spies C, Lefrant JY, De Backer D (2015) Fluid challenges in intensive care: the FENICE study: a global inception cohort study. Intensive Care Med 41:1529–1537
  53. Rhodes A, Phillips G, Beale R, Cecconi M, Chiche JD, De Backer D, Divatia J, Du B, Evans L, Ferrer R, Girardis M, Koulenti D, Machado F, Simpson SQ, Tan CC, Wittebole X, Levy M (2015) The Surviving Sepsis Campaign bundles and outcome: results from the International Multicentre Prevalence Study on Sepsis (the IMPreSS study). Intensive Care Med 41:1620–1628
  54. Angus DC, Barnato AE, Bell D, Bellomo R, Chong CR, Coats TJ, Davies A, Delaney A, Harrison DA, Holdgate A, Howe B, Huang DT, Iwashyna T, Kellum JA, Peake SL, Pike F, Reade MC, Rowan KM, Singer M, Webb SA, Weissfeld LA, Yealy DM, Young JD (2015) A systematic review and meta-analysis of early goal-directed therapy for septic shock: the ARISE, ProCESS and ProMISe Investigators. Intensive Care Med 41:1549–1560
  55. Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, Kumar A, Sevransky JE, Sprung CL, Nunnally ME, Rochwerg B, Rubenfeld GD, Angus DC, Annane D, Beale RJ, Bellinghan GJ, Bernard GR, Chiche JD, Coopersmith C, De Backer DP, French CJ, Fujishima S, Gerlach H, Hidalgo JL, Hollenberg SM, Jones AE, Karnad DR, Kleinpell RM, Koh Y, Lisboa TC, Machado FR, Marini JJ, Marshall JC, Mazuski JE, McIntyre LA, McLean AS, Mehta S, Moreno RP, Myburgh J, Navalesi P, Nishida O, Osborn TM, Perner A, Plunkett CM, Ranieri M, Schorr CA, Seckel MA, Seymour CW, Shieh L, Shukri KA, Simpson SQ, Singer M, Thompson BT, Townsend SR, Van der Poll T, Vincent JL, Wiersinga WJ, Zimmerman JL, Dellinger RP (2017) Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med 43:304–377
  56. Darmon M, Vincent F, Canet E, Mokart D, Pene F, Kouatchet A, Mayaux J, Nyunga M, Bruneel F, Rabbat A, Lebert C, Perez P, Renault A, Meert AP, Benoit D, Hamidfar R, Jourdain M, Schlemmer B, Chevret S, Lemiale V, Azoulay E (2006) Acute kidney injury in critically ill patients with haematological malignancies: results of a multicentre cohort study from the Groupe de Recherche en Reanimation Respiratoire en Onco-Hematologie. Nephrol Dial Transplant 30:2006–2013
    • View reference on publisher's website
  57. Soares M, Salluh JI, Carvalho MS, Darmon M, Rocco JR, Spector N (2006) Prognosis of critically ill patients with cancer and acute renal dysfunction. J Clin Oncol 24:4003–4010
    • View reference on PubMed
    • View reference on publisher's website
  58. Darmon M, Vincent F, Camous L, Canet E, Bonmati C, Braun T, Caillot D, Cornillon J, Dimicoli S, Etienne A, Galicier L, Garnier A, Girault S, Hunault-Berger M, Marolleau JP, Moreau P, Raffoux E, Recher C, Thiebaud A, Thieblemont C, Azoulay E (2013) Tumour lysis syndrome and acute kidney injury in high-risk haematology patients in the rasburicase era. A prospective multicentre study from the Groupe de Recherche en Reanimation Respiratoire et Onco-Hematologique. Br J Haematol 162:489–497
    • View reference on PubMed
    • View reference on publisher's website
  59. Bai M, Zhou M, He L, Ma F, Li Y, Yu Y, Wang P, Li L, Jing R, Zhao L, Sun S (2015) Citrate versus heparin anticoagulation for continuous renal replacement therapy: an updated meta-analysis of RCTs. Intensive Care Med 41:2098–2110
  60. Rygard SL, Holst LB, Wetterslev J, Johansson PI, Perner A (2016) Higher vs. lower haemoglobin threshold for transfusion in septic shock: subgroup analyses of the TRISS trial. Acta Anaesthesiol Scand 61:166–175
    • View reference on PubMed
    • View reference on publisher's website
  61. Holst LB, Haase N, Wetterslev J, Wernerman J, Guttormsen AB, Karlsson S, Johansson PI, Aneman A, Vang ML, Winding R, Nebrich L, Nibro HL, Rasmussen BS, Lauridsen JR, Nielsen JS, Oldner A, Pettila V, Cronhjort MB, Andersen LH, Pedersen UG, Reiter N, Wiis J, White JO, Russell L, Thornberg KJ, Hjortrup PB, Muller RG, Moller MH, Steensen M, Tjader I, Kilsand K, Odeberg-Wernerman S, Sjobo B, Bundgaard H, Thyo MA, Lodahl D, Maerkedahl R, Albeck C, Illum D, Kruse M, Winkel P, Perner A (2014) Lower versus higher hemoglobin threshold for transfusion in septic shock. N Engl J Med 371:1381–1391
    • View reference on PubMed
    • View reference on publisher's website
  62. de Almeida JP, Vincent JL, Galas FR, de Almeida EP, Fukushima JT, Osawa EA, Bergamin F, Park CL, Nakamura RE, Fonseca SM, Cutait G, Alves JI, Bazan M, Vieira S, Sandrini AC, Palomba H, Ribeiro U Jr, Crippa A, Dalloglio M, Diz Mdel P, Kalil Filho R, Auler JO Jr, Rhodes A, Hajjar LA (2015) Transfusion requirements in surgical oncology patients: a prospective, randomized controlled trial. Anesthesiology 122:29–38
    • View reference on PubMed
    • View reference on publisher's website
  63. Stanworth SJ, Estcourt LJ, Powter G, Kahan BC, Dyer C, Choo L, Bakrania L, Llewelyn C, Littlewood T, Soutar R, Norfolk D, Copplestone A, Smith N, Kerr P, Jones G, Raj K, Westerman DA, Szer J, Jackson N, Bardy PG, Plews D, Lyons S, Bielby L, Wood EM, Murphy MF (2013) A no-prophylaxis platelet-transfusion strategy for hematologic cancers. N Engl J Med 368:1771–1780
    • View reference on PubMed
    • View reference on publisher's website
  64. Wandt H, Schaefer-Eckart K, Wendelin K, Pilz B, Wilhelm M, Thalheimer M, Mahlknecht U, Ho A, Schaich M, Kramer M, Kaufmann M, Leimer L, Schwerdtfeger R, Conradi R, Dolken G, Klenner A, Hanel M, Herbst R, Junghanss C, Ehninger G (2012) Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study. Lancet 380:1309–1316
    • View reference on PubMed
    • View reference on publisher's website
  65. Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, Raad II, Rolston KV, Young JA, Wingard JR (2011) Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 52:e56–e93
    • View reference on PubMed
    • View reference on publisher's website
  66. Patterson TF, Thompson GR 3rd, Denning DW, Fishman JA, Hadley S, Herbrecht R, Kontoyiannis DP, Marr KA, Morrison VA, Nguyen MH, Segal BH, Steinbach WJ, Stevens DA, Walsh TJ, Wingard JR, Young JA, Bennett JE (2016) Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis 63:e1–e60
    • View reference on PubMed
    • View reference on publisher's website
  67. Schnell D, Azoulay E, Benoit D, Clouzeau B, Demaret P, Ducassou S, Frange P, Lafaurie M, Legrand M, Meert AP, Mokart D, Naudin J, Pene F, Rabbat A, Raffoux E, Ribaud P, Richard JC, Vincent F, Zahar JR, Darmon M (2016) Management of neutropenic patients in the intensive care unit (NEWBORNS EXCLUDED) recommendations from an expert panel from the French Intensive Care Society (SRLF) with the French Group for Pediatric Intensive Care Emergencies (GFRUP), the French Society of Anesthesia and Intensive Care (SFAR), the French Society of Hematology (SFH), the French Society for Hospital Hygiene (SF2H), and the French Infectious Diseases Society (SPILF). Ann Intensive Care 6:90
    • View reference on PubMed
    • View reference on publisher's website
  68. Puxty K, McLoone P, Quasim T, Kinsella J, Morrison D (2016) Survival in solid cancer patients following intensive care unit admission. Intensive Care Med 40:1409–1428
  69. Puxty K, McLoone P, Quasim T, Sloan B, Kinsella J, Morrison DS (2015) Risk of critical illness among patients with solid cancers: a population-based observational study. JAMA Oncol 1:1078–1085
    • View reference on PubMed
    • View reference on publisher's website
  70. Soares M, Caruso P, Silva E, Teles JM, Lobo SM, Friedman G, Dal Pizzol F, Mello PV, Bozza FA, Silva UV, Torelly AP, Knibel MF, Rezende E, Netto JJ, Piras C, Castro A, Ferreira BS, Rea-Neto A, Olmedo PB, Salluh JI (2010) Characteristics and outcomes of patients with cancer requiring admission to intensive care units: a prospective multicenter study. Crit Care Med 38:9–15
    • View reference on PubMed
    • View reference on publisher's website
  71. Taccone FS, Artigas AA, Sprung CL, Moreno R, Sakr Y, Vincent JL (2009) Characteristics and outcomes of cancer patients in European ICUs. Crit Care 13:R15
    • View reference on PubMed
    • View reference on publisher's website
  72. Staudinger T, Stoiser B, Mullner M, Locker GJ, Laczika K, Knapp S, Burgmann H, Wilfing A, Kofler J, Thalhammer F, Frass M (2000) Outcome and prognostic factors in critically ill cancer patients admitted to the intensive care unit. Crit Care Med 28:1322–1328
    • View reference on PubMed
    • View reference on publisher's website
  73. Austin CA, Hanzaker C, Stafford R, Mayer C, Culp L, Lin FC, Chang L (2014) Utilization of rapid response resources and outcomes in a comprehensive cancer center. Crit Care Med 42:905–909
    • View reference on PubMed
    • View reference on publisher's website
  74. Jung B, Daurat A, De Jong A, Chanques G, Mahul M, Monnin M, Molinari N, Jaber S (2016) Rapid response team and hospital mortality in hospitalized patients. Intensive Care Med 42:494–504
  75. Jones D, Warrillow S (2014) Clinical deterioration in cancer patients—the role of the rapid response team. Crit Care Med 42:997–998
    • View reference on PubMed
    • View reference on publisher's website
  76. De Jong A, Jung B, Daurat A, Chanques G, Mahul M, Monnin M, Molinari N, Jaber S (2016) Effect of rapid response systems on hospital mortality: a systematic review and meta-analysis. Intensive Care Med 42:615–617
  77. Song JU, Suh GY, Park HY, Lim SY, Han SG, Kang YR, Kwon OJ, Woo S, Jeon K (2012) Early intervention on the outcomes in critically ill cancer patients admitted to intensive care units. Intensive Care Med 38:1505–1513
  78. Hawari FI, Al Najjar TI, Zaru L, Al Fayoumee W, Salah SH, Mukhaimar MZ (2009) The effect of implementing high-intensity intensive care unit staffing model on outcome of critically ill oncology patients. Crit Care Med 37:1967–1971
    • View reference on PubMed
    • View reference on publisher's website
  79. Zuber B, Tran TC, Aegerter P, Grimaldi D, Charpentier J, Guidet B, Mira JP, Pene F (2012) Impact of case volume on survival of septic shock in patients with malignancies. Crit Care Med 40:55–62
    • View reference on PubMed
    • View reference on publisher's website
  80. Legrand M, Max A, Peigne V, Mariotte E, Canet E, Debrumetz A, Lemiale V, Seguin A, Darmon M, Schlemmer B, Azoulay E (2012) Survival in neutropenic patients with severe sepsis or septic shock. Crit Care Med 40:43–49
    • View reference on PubMed
    • View reference on publisher's website
  81. Perner A, Gordon AC, De Backer D, Dimopoulos G, Russell JA, Lipman J, Jensen JU, Myburgh J, Singer M, Bellomo R, Walsh T (2016) Sepsis: frontiers in diagnosis, resuscitation and antibiotic therapy. Intensive Care Med 42:1958–1969
  82. Sachak T, Arnold MA, Naini BV, Graham RP, Shah SS, Cruise M, Park JY, Clark L, Lamps L, Frankel WL, Theodoropoulos N, Arnold CA (2015) Neutropenic enterocolitis: new insights into a deadly entity. Am J Surg Pathol 39:1635–1642
    • View reference on PubMed
    • View reference on publisher's website
  83. Mokart D, Slehofer G, Lambert J, Sannini A, Chow-Chine L, Brun JP, Berger P, Duran S, Faucher M, Blache JL, Saillard C, Vey N, Leone M (2014) De-escalation of antimicrobial treatment in neutropenic patients with severe sepsis: results from an observational study. Intensive Care Med 40:41–49
  84. Darmon M, Azoulay E, Alberti C, Fieux F, Moreau D, Le Gall JR, Schlemmer B (2002) Impact of neutropenia duration on short-term mortality in neutropenic critically ill cancer patients. Intensive Care Med 28:1775–1780
  85. Azoulay E, Darmon M, Delclaux C, Fieux F, Bornstain C, Moreau D, Attalah H, Le Gall JR, Schlemmer B (2002) Deterioration of previous acute lung injury during neutropenia recovery. Crit Care Med 30:781–786
    • View reference on PubMed
    • View reference on publisher's website
  86. Azoulay E, Attalah H, Yang K, Jouault H, Schlemmer B, Brun-Buisson C, Brochard L, Harf A, Delclaux C (2002) Exacerbation by granulocyte colony-stimulating factor of prior acute lung injury: implication of neutrophils. Crit Care Med 30:2115–2122
    • View reference on PubMed
    • View reference on publisher's website
  87. Azoulay E, Attalah H, Harf A, Schlemmer B, Delclaux C (2001) Granulocyte colony-stimulating factor or neutrophil-induced pulmonary toxicity: myth or reality? Systematic review of clinical case reports and experimental data. Chest 120:1695–1701
    • View reference on PubMed
    • View reference on publisher's website
  88. Seguin A, Galicier L, Boutboul D, Lemiale V, Azoulay E (2015) Pulmonary involvement in patients with hemophagocytic lymphohistiocytosis. Chest 149:1294–1301
    • View reference on publisher's website
  89. Creput C, Galicier L, Buyse S, Azoulay E (2008) Understanding organ dysfunction in hemophagocytic lymphohistiocytosis. Intensive Care Med 34:1177–1187
  90. Buyse S, Teixeira L, Galicier L, Mariotte E, Lemiale V, Seguin A, Bertheau P, Canet E, de Labarthe A, Darmon M, Rybojad M, Schlemmer B, Azoulay E (2010) Critical care management of patients with hemophagocytic lymphohistiocytosis. Intensive Care Med 36:1695–1702
  91. Benoit DD, Depuydt PO, Vandewoude KH, Offner FC, Boterberg T, De Cock CA, Noens LA, Janssens AM, Decruyenaere JM (2006) Outcome in severely ill patients with hematological malignancies who received intravenous chemotherapy in the intensive care unit. Intensive Care Med 32:93–99
  92. Wohlfarth P, Staudinger T, Sperr WR, Bojic A, Robak O, Hermann A, Laczika K, Carlstrom A, Riss K, Rabitsch W, Bojic M, Knoebl P, Locker GJ, Obiditsch M, Fuhrmann V, Schellongowski P (2014) Prognostic factors, long-term survival, and outcome of cancer patients receiving chemotherapy in the intensive care unit. Ann Hematol 93:1629–1636
    • View reference on PubMed
    • View reference on publisher's website
  93. Darmon M, Thiery G, Ciroldi M, de Miranda S, Galicier L, Raffoux E, Le Gall JR, Schlemmer B, Azoulay E (2005) Intensive care in patients with newly diagnosed malignancies and a need for cancer chemotherapy. Crit Care Med 33:2488–2493
    • View reference on PubMed
    • View reference on publisher's website
  94. Lecuyer L, Chevret S, Thiery G, Darmon M, Schlemmer B, Azoulay E (2007) The ICU trial: a new admission policy for cancer patients requiring mechanical ventilation. Crit Care Med 35:808–814
    • View reference on PubMed
    • View reference on publisher's website
  95. Shrime MG, Ferket BS, Scott DJ, Lee J, Barragan-Bradford D, Pollard T, Arabi YM, Al-Dorzi HM, Baron RM, Hunink MG, Celi LA, Lai PS (2016) Time-limited trials of intensive care for critically ill patients with cancer: how long is long enough? JAMA Oncol 2:76–83
    • View reference on PubMed
    • View reference on publisher's website
  96. Zampieri FG, Bozza FA, Moralez GM, Mazza DD, Scotti AV, Santino MS, Ribeiro RA, Rodrigues Filho EM, Cabral MM, Maia MO, D’Alessandro PS, Oliveira SV, Menezes MA, Caser EB, Lannes RS, Alencar Neto MS, Machado MM, Sousa MF, Salluh JI, Soares M (2017) The effects of performance status one week before hospital admission on the outcomes of critically ill patients. Intensive Care Med 43:39–47
  97. Bouteloup M, Perinel S, Bourmaud A, Azoulay E, Mokart D, Darmon M (2016) Outcomes in adult critically ill cancer patients with and without neutropenia: a systematic review and meta-analysis of the Groupe de Recherche en Reanimation Respiratoire du patient d’Onco-Hematologie (GRRR-OH). Oncotarget 8:1860–1870
  98. van Vliet M, Verburg IW, van den Boogaard M, de Keizer NF, Peek N, Blijlevens NM, Pickkers P (2014) Trends in admission prevalence, illness severity and survival of haematological patients treated in Dutch intensive care units. Intensive Care Med 40:1275–1284
  99. Bassetti M, De Waele JJ, Eggimann P, Garnacho-Montero J, Kahlmeter G, Menichetti F, Nicolau DP, Paiva JA, Tumbarello M, Welte T, Wilcox M, Zahar JR, Poulakou G (2015) Preventive and therapeutic strategies in critically ill patients with highly resistant bacteria. Intensive Care Med 41:776–795
  100. Azoulay E, Schlemmer B (2006) Diagnostic strategy in cancer patients with acute respiratory failure. Intensive Care Med 32:808–822
  101. Sprung CL, Danis M, Iapichino G, Artigas A, Kesecioglu J, Moreno R, Lippert A, Curtis JR, Meale P, Cohen SL, Levy MM, Truog RD (2013) Triage of intensive care patients: identifying agreement and controversy. Intensive Care Med 39:1916–1924
  102. Melot C (2015) To score or not to score during triage in the emergency department? Intensive Care Med 41:1135–1137
  103. Thiery G, Azoulay E, Darmon M, Ciroldi M, De Miranda S, Levy V, Fieux F, Moreau D, Le Gall JR, Schlemmer B (2005) Outcome of cancer patients considered for intensive care unit admission: a hospital-wide prospective study. J Clin Oncol 23:4406–4413
    • View reference on PubMed
    • View reference on publisher's website
  104. Azoulay E, Kouatchet A, Jaber S, Lambert J, Meziani F, Schmidt M, Schnell D, Mortaza S, Conseil M, Tchenio X, Herbecq P, Andrivet P, Guerot E, Lafabrie A, Perbet S, Camous L, Janssen-Langenstein R, Collet F, Messika J, Legriel S, Fabre X, Guisset O, Touati S, Kilani S, Alves M, Mercat A, Similowski T, Papazian L, Meert AP, Chevret S, Schlemmer B, Brochard L, Demoule A (2013) Noninvasive mechanical ventilation in patients having declined tracheal intubation. Intensive Care Med 39:292–301
  105. Lecuyer L, Chevret S, Guidet B, Aegerter P, Martel P, Schlemmer B, Azoulay E (2008) Case volume and mortality in haematological patients with acute respiratory failure. Eur Respir J 32:748–754
    • View reference on PubMed
    • View reference on publisher's website
  106. Merceron S, Canet E, Lemiale V, Azoulay E (2014) Palliative vasoactive therapy in patients with septic shock. Chest 146:e107–e108
    • View reference on PubMed
    • View reference on publisher's website
  107. Toffart AC, Dhalluin X, Girard N, Chouaid C, Audigier-Valette C, Duruisseaux M, Mennecier B, Parrot A, Fournel P, Moro-Sibilot D, Timsit JF (2015) Patients with advanced lung cancer harboring oncogenic mutations should be admitted to intensive care units. Intensive Care Med 41:164–165
  108. BCSH (2015) Guidelines on the management and admission to intensive care of critically ill adult patients with hematological malignancy in the UK. http://www.bcshguidelines.com/documents/ITU.pdf. Accessed 15 Mar 2017
  109. Soares M, Bozza FA, Angus DC, Japiassu AM, Viana WN, Costa R, Brauer L, Mazza BF, Correa TD, Nunes AL, Lisboa T, Colombari F, Maciel AT, Azevedo LC, Damasceno M, Fernandes HS, Cavalcanti AB, do Brasil PE, Kahn JM, Salluh JI (2015) Organizational characteristics, outcomes, and resource use in 78 Brazilian intensive care units: the ORCHESTRA study. Intensive Care Med 41:2149–2160
  110. Prigerson HG, Bao Y, Shah MA, Paulk ME, LeBlanc TW, Schneider BJ, Garrido MM, Reid MC, Berlin DA, Adelson KB, Neugut AI, Maciejewski PK (2016) Chemotherapy use, performance status, and quality of life at the end of life. JAMA Oncol 1:778–784
    • View reference on publisher's website
  111. Wohlfarth P, Beutel G, Lebiedz P, Stemmler H, Staudinger T, Schmidt M, Kochanek M, Liebregts T, Taccone F, Azoulay E, Demoule A, Kluge S, Svalebjørg M, Luck C, Tischer J, Combes A, Böll B, Rabitsch W, Schellongowski P (2017) Characteristics and outcome of patients after allogeneic stem cell transplantation treated with extracorporeal membrane oxygenation for acute respiratory distress syndrome. Crit Care Med 45:e500–e507
  112. Oeyen SG, Benoit DD, Annemans L, Depuydt PO, Van Belle SJ, Troisi RI, Noens LA, Pattyn P, Decruyenaere JM (2013) Long-term outcomes and quality of life in critically ill patients with hematological or solid malignancies: a single center study. Intensive Care Med 39:889–898
  113. Schellongowski P, Benesch M, Lang T, Traunmuller F, Zauner C, Laczika K, Locker GJ, Frass M, Staudinger T (2004) Comparison of three severity scores for critically ill cancer patients. Intensive Care Med 30:430–436
  114. Normilio-Silva K, de Figueiredo AC, Pedroso-de-Lima AC, Tunes-da-Silva G, da Silva AN, Levites ADD, de-Simone AT, Safra PL, Zancani R, Tonini PC, de Andrade ESUV, Buosi Silva T, Martins Giorgi J, Eluf-Neto J, Costa A, Abrahao Hajjar L, Biasi Cavalcanti A (2016) Long-term survival, quality of life, and quality-adjusted survival in critically ill patients with cancer. Crit Care Med 44:1327–1337
    • View reference on PubMed
    • View reference on publisher's website
  115. Azevedo LC, Caruso P, Silva UV, Torelly AP, Silva E, Rezende E, Netto JJ, Piras C, Lobo SM, Knibel MF, Teles JM, Lima RA, Ferreira BS, Friedman G, Rea-Neto A, Dal-Pizzol F, Bozza FA, Salluh JI, Soares M (2014) Outcomes for patients with cancer admitted to the ICU requiring ventilatory support: results from a prospective multicenter study. Chest 146:257–266
    • View reference on PubMed
    • View reference on publisher's website
  116. Massion PB, Dive AM, Doyen C, Bulpa P, Jamart J, Bosly A, Installe E (2002) Prognosis of hematologic malignancies does not predict intensive care unit mortality. Crit Care Med 30:2260–2270
    • View reference on PubMed
    • View reference on publisher's website
  117. van Vliet M, van den Boogaard M, Donnelly JP, Evers AW, Blijlevens NM, Pickkers P (2014) Long-term health related quality of life following intensive care during treatment for haematological malignancies. PLoS One 9:e87779
    • View reference on PubMed
    • View reference on publisher's website
  118. Chanques G, Nelson J, Puntillo K (2015) Five patient symptoms that you should evaluate every day. Intensive Care Med 41:1347–1350
  119. Wright AA, Zhang B, Keating NL, Weeks JC, Prigerson HG (2014) Associations between palliative chemotherapy and adult cancer patients’ end of life care and place of death: prospective cohort study. BMJ 348:g1219
    • View reference on PubMed
    • View reference on publisher's website
  120. Nelson JE, Meier DE, Oei EJ, Nierman DM, Senzel RS, Manfredi PL, Davis SM, Morrison RS (2001) Self-reported symptom experience of critically ill cancer patients receiving intensive care. Crit Care Med 29:277–282
    • View reference on PubMed
    • View reference on publisher's website
  121. Saillard C, Blaise D, Mokart D (2016) Critically ill allogeneic hematopoietic stem cell transplantation patients in the intensive care unit: reappraisal of actual prognosis. Bone Marrow Transplant 51:1050–1061
    • View reference on PubMed
    • View reference on publisher's website
  122. Lengline E, Chevret S, Moreau AS, Pene F, Blot F, Bourhis JH, Buzyn A, Schlemmer B, Socie G, Azoulay E (2015) Changes in intensive care for allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant 50:840–845
    • View reference on PubMed
    • View reference on publisher's website
  123. Papazian L, Corley A, Hess D, Fraser JF, Frat JP, Guitton C, Jaber S, Maggiore SM, Nava S, Rello J, Ricard JD, Stephan F, Trisolini R, Azoulay E (2016) Use of high-flow nasal cannula oxygenation in ICU adults: a narrative review. Intensive Care Med 42:1336–1349
  124. Mokart D, Geay C, Chow-Chine L, Brun JP, Faucher M, Blache JL, Bisbal M, Sannini A (2015) High-flow oxygen therapy in cancer patients with acute respiratory failure. Intensive Care Med 41:2008–2010
  125. Antonelli M, Conti G, Rocco M, Bufi M, De Blasi RA, Vivino G, Gasparetto A, Meduri GU (1998) A comparison of noninvasive positive-pressure ventilation and conventional mechanical ventilation in patients with acute respiratory failure. N Engl J Med 339:429–435
    • View reference on PubMed
    • View reference on publisher's website
  126. Nair GB, Niederman MS (2015) Ventilator-associated pneumonia: present understanding and ongoing debates. Intensive Care Med 41:34–48
  127. Albrich WC, Harbarth S (2015) Pros and cons of using biomarkers versus clinical decisions in start and stop decisions for antibiotics in the critical care setting. Intensive Care Med 41:1739–1751
  128. Caliendo AM, Gilbert DN, Ginocchio CC, Hanson KE, May L, Quinn TC, Tenover FC, Alland D, Blaschke AJ, Bonomo RA, Carroll KC, Ferraro MJ, Hirschhorn LR, Joseph WP, Karchmer T, MacIntyre AT, Reller LB, Jackson AF (2013) Better tests, better care: improved diagnostics for infectious diseases. Clin Infect Dis 57(Suppl 3):S139–S170
    • View reference on PubMed
    • View reference on publisher's website
  129. Jensen JU, Bouadma L (2016) Why biomarkers failed in sepsis. Intensive Care Med 42:2049–2051
  130. Mekontso Dessap A, Ware LB, Bouadma L (2016) What’s new with biomarker-driven clinical strategy in sepsis and circulatory failure? Intensive Care Med 42:418–421
  131. Rabello LS, Lisboa T, Soares M, Salluh JI (2015) Personalized treatment of severe pneumonia in cancer patients. Expert Rev Anti Infect Ther 13:1319–1324
    • View reference on PubMed
    • View reference on publisher's website
  132. Azoulay E, Guigue N, Darmon M, Mokart D, Lemiale V, Kouatchet A, Mayaux J, Vincent F, Nyunga M, Bruneel F, Rabbat A, Bretagne S, Lebert C, Meert AP, Benoit D, Pene F (2016) (1,3)-Beta-d-glucan assay for diagnosing invasive fungal infections in critically ill patients with hematological malignancies. Oncotarget 7:21484–21495
    • View reference on PubMed
    • View reference on publisher's website
  133. Robinson JO, Lamoth F, Bally F, Knaup M, Calandra T, Marchetti O (2011) Monitoring procalcitonin in febrile neutropenia: what is its utility for initial diagnosis of infection and reassessment in persistent fever? PLoS One 6:e18886
    • View reference on PubMed
    • View reference on publisher's website
  134. Kellum JA, Bellomo R, Ronco C (2016) Does this patient have acute kidney injury? An AKI checklist. Intensive Care Med 42:96–99
  135. Prowle JR (2015) Measurement of AKI biomarkers in the ICU: still striving for appropriate clinical indications. Intensive Care Med 41:541–543
  136. Legrand M, Jacquemod A, Gayat E, Collet C, Giraudeaux V, Launay JM, Payen D (2015) Failure of renal biomarkers to predict worsening renal function in high-risk patients presenting with oliguria. Intensive Care Med 41:68–76
  137. Hoste EA, Bagshaw SM, Bellomo R, Cely CM, Colman R, Cruz DN, Edipidis K, Forni LG, Gomersall CD, Govil D, Honore PM, Joannes-Boyau O, Joannidis M, Korhonen AM, Lavrentieva A, Mehta RL, Palevsky P, Roessler E, Ronco C, Uchino S, Vazquez JA, Vidal Andrade E, Webb S, Kellum JA (2015) Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med 41:1411–1423
  138. Zarbock A, Kellum JA, Schmidt C, Van Aken H, Wempe C, Pavenstadt H, Boanta A, Gerss J, Meersch M (2016) Effect of early vs delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury: the ELAIN randomized clinical trial. JAMA 315:2190–2199
    • View reference on publisher's website
  139. Almeida IC, Soares M, Bozza FA, Shinotsuka CR, Bujokas R, Souza-Dantas VC, Ely EW, Salluh JI (2014) The impact of acute brain dysfunction in the outcomes of mechanically ventilated cancer patients. PLoS One 9:e85332
    • View reference on PubMed
    • View reference on publisher's website
  140. Pandharipande PP, Girard TD, Jackson JC, Morandi A, Thompson JL, Pun BT, Brummel NE, Hughes CG, Vasilevskis EE, Shintani AK, Moons KG, Geevarghese SK, Canonico A, Hopkins RO, Bernard GR, Dittus RS, Ely EW (2013) Long-term cognitive impairment after critical illness. N Engl J Med 369:1306–1316
    • View reference on PubMed
    • View reference on publisher's website
  141. Teuwen LA, Van den Mooter T, Dirix L (2015) Management of pulmonary toxicity associated with targeted anticancer therapies. Expert Opin Drug Metab Toxicol 11:1695–1707
    • View reference on PubMed
    • View reference on publisher's website
  142. Barber NA, Ganti AK (2011) Pulmonary toxicities from targeted therapies: a review. Target Oncol 6:235–243
    • View reference on PubMed
    • View reference on publisher's website
  143. de Margerie-Mellon C, de Bazelaire C, Amorim S, Brice P, Tazi A, Briere J, Frija J, de Kerviler E (2015) Diagnostic yield and safety of computed tomography-guided mediastinal core needle biopsies. J Thorac Imaging 30:319–327
    • View reference on PubMed
    • View reference on publisher's website
  144. Azoulay E, Canet E, Raffoux E, Lengline E, Lemiale V, Vincent F, de Labarthe A, Seguin A, Boissel N, Dombret H, Schlemmer B (2012) Dexamethasone in patients with acute lung injury from acute monocytic leukaemia. Eur Respir J 39:648–653
    • View reference on PubMed
    • View reference on publisher's website
  145. Kang HS, Rhee CK, Lee HY, Kim YK, Kwon SS, Kim SC, Lee JW (2015) Clinical outcomes of extracorporeal membrane oxygenation support in patients with hematologic malignancies. Korean J Intern Med 30:478–488
    • View reference on PubMed
    • View reference on publisher's website
  146. Peek GJ, Mugford M, Tiruvoipati R, Wilson A, Allen E, Thalanany MM, Hibbert CL, Truesdale A, Clemens F, Cooper N, Firmin RK, Elbourne D (2009) Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet 374:1351–1363
    • View reference on PubMed
    • View reference on publisher's website
  147. Afessa B, Tefferi A, Hoagland HC, Letendre L, Peters SG (1992) Outcome of recipients of bone marrow transplants who require intensive-care unit support. Mayo Clin Proc 67:117–122
    • View reference on PubMed
    • View reference on publisher's website
  148. Mayer S, Pastores SM, Riedel E, Maloy M, Jakubowski AA (2017) Short- and long-term outcomes of adult allogeneic hematopoietic stem cell transplant patients admitted to the intensive care unit in the peritransplant period. Leuk Lymphoma 58:382–390
    • View reference on PubMed
    • View reference on publisher's website
  149. van Vliet M, van der Burgt MP, van der Velden WJ, van der Hoeven JG, de Haan AF, Donnelly JP, Pickkers P, Blijlevens NM (2014) Trends in the outcomes of Dutch haematological patients receiving intensive care support. Neth J Med 72:107–112
    • View reference on PubMed

Sign In

Connect with ICM

Top 5 Articles Editors Picks Supplement